{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T17:40:47Z","timestamp":1652809247794},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.arteri.2015.05.001","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T17:39:04Z","timestamp":1436117944000},"page":"197-201","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Riesgo vascular en enfermedades endocrinol\u00f3gicas distintas a la diabetes"],"prefix":"10.1016","volume":"28","author":[{"given":"Isabel","family":"Antequera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 I.","family":"Cuende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jer\u00f3nimo","family":"Nieto L\u00f3pez-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Valdivielso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2015.05.001_bib0240","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/EJE-14-0355","article-title":"The PRIMARA study: A prospective, descriptive, observational study to review Cinacalcet use in patients with primary hyperparathyroidism in clinical practice","volume":"171","author":"Schwarz","year":"2014","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.arteri.2015.05.001_bib0245","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jss.2014.04.010","article-title":"Primary hyperparathyroidism across the ages: Presentation and outcomes","volume":"190","author":"Oltmann","year":"2014","journal-title":"J Surg Res."},{"key":"10.1016\/j.arteri.2015.05.001_bib0250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2362.1998.00289.x","article-title":"Increased risk of death from primary hyperparathyroidism\u2014an update","volume":"28","author":"Hedback","year":"1998","journal-title":"Eur J Clin Invest."},{"key":"10.1016\/j.arteri.2015.05.001_bib0255","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.ehj.2004.07.010","article-title":"Primary hyperparathyroidism and heart disease\u2014a review","volume":"25","author":"Andersson","year":"2004","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2015.05.001_bib0260","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4158\/EP12440.RA","article-title":"Association of plasma parathyroid hormone with metabolic syndrome and risk for cardiovascular disease","volume":"19","author":"Huang","year":"2013","journal-title":"Endocr Pract."},{"key":"10.1016\/j.arteri.2015.05.001_bib0265","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","article-title":"Plasma parathyroid hormone and the risk of cardiovascular mortality in the community","volume":"119","author":"Hagstrom","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2015.05.001_bib0270","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/jc.2009-1086","article-title":"Carotid vascular abnormalities in primary hyperparathyroidism","volume":"94","author":"Walker","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2015.05.001_bib0275","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/EJE-12-0124","article-title":"Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism","volume":"167","author":"Walker","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.arteri.2015.05.001_bib0280","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2265.2012.04485.x","article-title":"Endothelial function in mild primary hyperparathyroidism","volume":"78","author":"Carrelli","year":"2013","journal-title":"Clin Endocrinol."},{"key":"10.1016\/j.arteri.2015.05.001_bib0285","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.111.081307","article-title":"Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy","volume":"126","author":"Osto","year":"2012","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2015.05.001_bib0290","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.surg.2013.06.047","article-title":"Cardiovascular dysfunction in symptomatic primary hyperparathyroidism and its reversal after curative parathyroidectomy: Results of a prospective case control study","volume":"154","author":"Agarwal","year":"2013","journal-title":"Surgery."},{"key":"10.1016\/j.arteri.2015.05.001_bib0295","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/jc.2009-2072","article-title":"Cardiac structure and diastolic function in mild primary hyperparathyroidism","volume":"95","author":"Walker","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2015.05.001_bib0300","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.mpmed.2013.06.007","article-title":"Cushing's syndrome","volume":"41","author":"Daniel","year":"2013","journal-title":"Medicine."},{"key":"10.1016\/j.arteri.2015.05.001_bib0305","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1575-0922(09)70191-3","article-title":"Prevalencia, etiolog\u00eda y cuadro cl\u00ednico del s\u00edndrome de Cushing","volume":"56","author":"Lahera Vargas","year":"2009","journal-title":"Endocrinol Nutr."},{"key":"10.1016\/j.arteri.2015.05.001_bib0310","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.arteri.2015.05.001_bib0315","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/jch.12153","article-title":"Identifiable hypertension: A new spectrum","volume":"15","author":"Krakoff","year":"2013","journal-title":"J Clin Hypertens."},{"key":"10.1016\/j.arteri.2015.05.001_bib0320","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2012-1323","article-title":"Screening of Cushing's syndrome in outpatients with type 2 diabetes: Results of a prospective multicentric study in Italy","volume":"97","author":"Terzolo","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2015.05.001_bib0325","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome: A population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"Suppl 1","key":"10.1016\/j.arteri.2015.05.001_bib0330","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000318566","article-title":"Cardiovascular disease in Cushing's syndrome: Heart versus vasculature","volume":"92","author":"De Leo","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.arteri.2015.05.001_bib0335","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/vhrm.2005.1.4.291","article-title":"Cardiovascular consequences of cortisol excess","volume":"1","author":"Whitworth","year":"2005","journal-title":"Vasc Health Risk Manag."},{"key":"10.1016\/j.arteri.2015.05.001_bib0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF03401535","article-title":"Pathogenesis of vascular complications in Cushing's syndrome","volume":"11","author":"Miljic","year":"2012","journal-title":"Hormones."},{"key":"10.1016\/j.arteri.2015.05.001_bib0345","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1210\/en.2012-1573","article-title":"Adverse cardiovascular outcomes of corticosteroid excess","volume":"153","author":"Pimenta","year":"2012","journal-title":"Endocrinology."},{"key":"10.1016\/j.arteri.2015.05.001_bib0350","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jc.2012-2893","article-title":"Predictors of mortality and long-term outcomes in treated Cushing's disease: A study of 346 patients","volume":"98","author":"Lambert","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2015.05.001_bib0355","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: Audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2015.05.001_bib0360","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2009.03610.x","article-title":"Should we evaluate for cardiovascular disease in patients with Cushing's syndrome?","volume":"71","author":"Fallo","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.arteri.2015.05.001_bib0365","doi-asserted-by":"crossref","first-page":"e4928","DOI":"10.1136\/bmj.e4928","article-title":"Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: Cohort study","volume":"345","author":"Fardet","year":"2012","journal-title":"BMJ."},{"key":"10.1016\/j.arteri.2015.05.001_bib0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1507\/endocrj.K09E-260","article-title":"Endothelial dysfunction associated with hypercortisolism is reversible in Cushing's syndrome","volume":"57","author":"Akaza","year":"2010","journal-title":"Endocr J."},{"key":"10.1016\/j.arteri.2015.05.001_bib0375","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-09-0621","article-title":"Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome","volume":"162","author":"Pereira","year":"2010","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.arteri.2015.05.001_bib0380","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2012-3754","article-title":"Hypercortisolism is associated with increased coronary arterial atherosclerosis: Analysis of noninvasive coronary angiography using multidetector computerized tomography","volume":"98","author":"Neary","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2015.05.001_bib0385","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2012-3547","article-title":"Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing's syndrome","volume":"98","author":"Barahona","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2015.05.001_bib0390","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"Suppl 1","key":"10.1016\/j.arteri.2015.05.001_bib0395","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000314294","article-title":"Management of dyslipidemia in Cushing's syndrome","volume":"92","author":"Greenman","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.arteri.2015.05.001_bib0400","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","article-title":"High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO\/ISH guidelines","volume":"61","author":"Mancini","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.arteri.2015.05.001_bib0405","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(04)15696-1","article-title":"Hypothyroidism","volume":"363","author":"Roberts","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.05.001_bib0410","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4321\/S1135-57272014000500007","article-title":"Different methods used to estimate the prevalence of hypothyroidism, Cadiz, Spain","volume":"88","author":"Escribano-Serrano","year":"2014","journal-title":"Rev Esp Salud Publica."},{"key":"10.1016\/j.arteri.2015.05.001_bib0415","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1507\/endocrj.K11E-012","article-title":"Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia","volume":"58","author":"Tagami","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.arteri.2015.05.001_bib0420","first-page":"37","article-title":"Relationship between lipoprotein(a) and thyroid hormones in hypothyroid patients","volume":"8","author":"Kaliaperumal","year":"2014","journal-title":"J Clin Diagn Res."},{"key":"10.1016\/j.arteri.2015.05.001_bib0425","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0974-2727.59698","article-title":"Serum levels of lipids, calcium and magnesium in women with hypothyroidism and cardiovascular diseases","volume":"1","author":"Al-Hakeim","year":"2009","journal-title":"J Lab Physicians"},{"key":"10.1016\/j.arteri.2015.05.001_bib0430","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1874192401105010076","article-title":"Effects of thyroid dysfunction on lipid profile","volume":"5","author":"Rizos","year":"2011","journal-title":"Open Cardiovasc Med J."},{"key":"10.1016\/j.arteri.2015.05.001_bib0435","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/cen.12064","article-title":"Relation between lipoprotein subfractions and TSH levels in the cardiovascular risk among women with subclinical hypothyroidism","volume":"78","author":"Hernandez-Mijares","year":"2013","journal-title":"Clin Endocrinol."},{"key":"10.1016\/j.arteri.2015.05.001_bib0440","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.amjmed.2005.09.028","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease: A meta-analysis","volume":"119","author":"Rodondi","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.arteri.2015.05.001_bib0445","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-148-11-200806030-00225","article-title":"Meta-analysis: Subclinical thyroid dysfunction and the risk for coronary heart disease and mortality","volume":"148","author":"Ochs","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arteri.2015.05.001_bib0450","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.arteri.2015.05.001_bib0455","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jacc.2012.03.047","article-title":"Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults","volume":"60","author":"Tseng","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arteri.2015.05.001_bib0460","first-page":"501","article-title":"Free thyroxine index and risk of stroke: Results from the National Health and Nutrition Examination Survey Follow-up Study","volume":"12","author":"Qureshi","year":"2006","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.arteri.2015.05.001_bib0465","first-page":"CD003419","article-title":"Thyroid hormone replacement for subclinical hypothyroidism","author":"Villar","year":"2007","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.arteri.2015.05.001_bib0470","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/M14-1456","article-title":"Screening and treatment of thyroid dysfunction: An evidence review for the U.S. Preventive Services Task Force","volume":"162","author":"Rugge","year":"2015","journal-title":"Ann Intern Med"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916815000674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916815000674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T17:16:56Z","timestamp":1652807816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916815000674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0214916815000674"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2015.05.001","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Riesgo vascular en enfermedades endocrinol\u00f3gicas distintas a la diabetes","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2015.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}